Logo image of SNES

SENESTECH INC (SNES) Stock Fundamental Analysis

NASDAQ:SNES - Nasdaq - US81720R6045 - Common Stock

2.98  -0.15 (-4.79%)

Fundamental Rating

3

Taking everything into account, SNES scores 3 out of 10 in our fundamental rating. SNES was compared to 195 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of SNES have multiple concerns. SNES is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year SNES has reported negative net income.
SNES had a negative operating cash flow in the past year.
In the past 5 years SNES always reported negative net income.
SNES had a negative operating cash flow in each of the past 5 years.
SNES Yearly Net Income VS EBIT VS OCF VS FCFSNES Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -5M -10M -15M

1.2 Ratios

The Return On Assets of SNES (-149.74%) is worse than 84.95% of its industry peers.
With a Return On Equity value of -182.47%, SNES is not doing good in the industry: 69.35% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -149.74%
ROE -182.47%
ROIC N/A
ROA(3y)-106.9%
ROA(5y)-132.23%
ROE(3y)-129.16%
ROE(5y)-198.69%
ROIC(3y)N/A
ROIC(5y)N/A
SNES Yearly ROA, ROE, ROICSNES Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500 -500 -1K -1.5K

1.3 Margins

SNES has a better Gross Margin (50.15%) than 60.75% of its industry peers.
SNES's Gross Margin has improved in the last couple of years.
SNES does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y17.7%
SNES Yearly Profit, Operating, Gross MarginsSNES Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -5K -10K -15K -20K

More info and screens

3

2. Health

2.1 Basic Checks

SNES does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SNES has been increased compared to 1 year ago.
SNES has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, SNES has a worse debt to assets ratio.
SNES Yearly Shares OutstandingSNES Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 100K 200K 300K 400K 500K
SNES Yearly Total Debt VS Total AssetsSNES Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

2.2 Solvency

SNES has an Altman-Z score of -43.73. This is a bad value and indicates that SNES is not financially healthy and even has some risk of bankruptcy.
SNES has a Altman-Z score of -43.73. This is amonst the worse of the industry: SNES underperforms 92.47% of its industry peers.
A Debt/Equity ratio of 0.05 indicates that SNES is not too dependend on debt financing.
The Debt to Equity ratio of SNES (0.05) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z -43.73
ROIC/WACCN/A
WACC10.63%
SNES Yearly LT Debt VS Equity VS FCFSNES Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M -10M

2.3 Liquidity

A Current Ratio of 6.32 indicates that SNES has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 6.32, SNES is in the better half of the industry, outperforming 71.51% of the companies in the same industry.
A Quick Ratio of 4.92 indicates that SNES has no problem at all paying its short term obligations.
With a decent Quick ratio value of 4.92, SNES is doing good in the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.32
Quick Ratio 4.92
SNES Yearly Current Assets VS Current LiabilitesSNES Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

8

3. Growth

3.1 Past

SNES shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 84.67%, which is quite impressive.
The Revenue has grown by 37.58% in the past year. This is a very strong growth!
The Revenue has been growing by 31.80% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)84.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96.33%
Revenue 1Y (TTM)37.58%
Revenue growth 3Y66.17%
Revenue growth 5Y31.8%
Sales Q2Q%33.89%

3.2 Future

SNES is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.59% yearly.
Based on estimates for the next years, SNES will show a very strong growth in Revenue. The Revenue will grow by 80.79% on average per year.
EPS Next Y96.61%
EPS Next 2Y40.69%
EPS Next 3Y25.59%
EPS Next 5YN/A
Revenue Next Year61.35%
Revenue Next 2Y81.19%
Revenue Next 3Y80.79%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SNES Yearly Revenue VS EstimatesSNES Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2M 4M 6M
SNES Yearly EPS VS EstimatesSNES Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -10K -20K -30K -40K -50K

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

SNES reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SNES. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SNES Price Earnings VS Forward Price EarningsSNES Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SNES Per share dataSNES EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15

4.3 Compensation for Growth

A more expensive valuation may be justified as SNES's earnings are expected to grow with 25.59% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.69%
EPS Next 3Y25.59%

More info and screens

0

5. Dividend

5.1 Amount

SNES does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SENESTECH INC

NASDAQ:SNES (1/22/2025, 10:19:13 AM)

2.98

-0.15 (-4.79%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-12 2024-11-12/amc
Earnings (Next)02-19 2025-02-19/amc
Inst Owners2.91%
Inst Owner Change0%
Ins Owners0.03%
Ins Owner Change0%
Market Cap3.07M
Analysts82.86
Price Target10.2 (242.28%)
Short Float %5.33%
Short Ratio0.37
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)21.11%
Min EPS beat(2)5.64%
Max EPS beat(2)36.58%
EPS beat(4)2
Avg EPS beat(4)-15.7%
Min EPS beat(4)-101.2%
Max EPS beat(4)36.58%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-13.01%
Min Revenue beat(2)-18.81%
Max Revenue beat(2)-7.22%
Revenue beat(4)0
Avg Revenue beat(4)-13.77%
Min Revenue beat(4)-23.89%
Max Revenue beat(4)-5.16%
Revenue beat(8)0
Avg Revenue beat(8)-23.6%
Revenue beat(12)0
Avg Revenue beat(12)-25%
Revenue beat(16)2
Avg Revenue beat(16)-16.02%
PT rev (1m)-71.43%
PT rev (3m)-71.43%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-900%
EPS NY rev (1m)0%
EPS NY rev (3m)7.09%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.88%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.86
P/FCF N/A
P/OCF N/A
P/B 0.84
P/tB 0.84
EV/EBITDA N/A
EPS(TTM)-17.78
EYN/A
EPS(NY)-6.36
Fwd EYN/A
FCF(TTM)-6.74
FCFYN/A
OCF(TTM)-6.63
OCFYN/A
SpS1.6
BVpS3.54
TBVpS3.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -149.74%
ROE -182.47%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 50.15%
FCFM N/A
ROA(3y)-106.9%
ROA(5y)-132.23%
ROE(3y)-129.16%
ROE(5y)-198.69%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y17.7%
F-Score4
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 71.23%
Cap/Sales 6.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.32
Quick Ratio 4.92
Altman-Z -43.73
F-Score4
WACC10.63%
ROIC/WACCN/A
Cap/Depr(3y)79.38%
Cap/Depr(5y)58.63%
Cap/Sales(3y)15.27%
Cap/Sales(5y)27.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96.33%
EPS Next Y96.61%
EPS Next 2Y40.69%
EPS Next 3Y25.59%
EPS Next 5YN/A
Revenue 1Y (TTM)37.58%
Revenue growth 3Y66.17%
Revenue growth 5Y31.8%
Sales Q2Q%33.89%
Revenue Next Year61.35%
Revenue Next 2Y81.19%
Revenue Next 3Y80.79%
Revenue Next 5YN/A
EBIT growth 1Y17.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year24.63%
EBIT Next 3Y16.45%
EBIT Next 5YN/A
FCF growth 1Y16.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y15.84%
OCF growth 3YN/A
OCF growth 5YN/A